Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Lajos Pusztai
Based on 159 articles published since 2008
||||
Expertise Level
The expertise of Lajos Pusztai ranks in the
  • Top 0.021%
  • ... of 255,217 published authors worldwide on Breast Neoplasms
  • ... from 2008 through 2018
  • ... based on contributions to 159 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Pusztai, Lajos   ·   Pusztai, L
Work Locations
Details
Most likely:    Yale University   Contact    
2018
  • Department of Medical, Surgery and Health Sciences, University of Trieste, Piazza Ospitale 1, Trieste, 34129, Italy. · UO Multidisciplinare di Patologia Mammaria e Ricerca Traslazionale, ASST di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Peter MacCallum Cancer Centre, Moorabbin Campus, 865 Centre Rd, Bentleigh East, VIC, 3165, Australia. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA. · Department of Surgical Oncology, Institut Curie-René Huguenin, 35 rue Dailly, St Cloud, France. · Department of Obstetrics and Gynaecology, Tenon University Hospital, Paris, France. · Pubmed 29344722
2017
  • Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT. · Pubmed 29048991
  • Yale University School of Medicine, New Haven, CT, USA. Electronic address: · Yale University School of Medicine, New Haven, CT, USA. · Pubmed 28987415
  • Department of Breast Medical Oncology. · Department of Biostatistics. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Breast and Endocrine Surgery, Okayama University, Okayama, Japan. · Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, USA. · Pubmed 28961844
  • Foundation Medicine, Inc., Cambridge. · Avera Cancer Institute, Sioux Falls. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas. · Sarah Cannon Research Institute, Nashville. · Eastchester Center for Cancer Care, Bronx. · Sutter Medical Group of the Redwoods, Santa Rosa. · Division of Medical Oncology, Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick. · Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore. · Weill Cornell Breast Center, Weill Cornell Medicine, New York. · Tufts University Medical Center, Boston. · Department of Breast Medical Oncology, Yale University, Yale Cancer Center, New Haven. · Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, USA. · Pubmed 28945887
  • Department of Surgery, Yale University School of Medicine, New Haven, CT, USA. Electronic address: · Department of Surgery, Yale University School of Medicine, New Haven, CT, USA. · Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, USA. · Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA. · Pubmed 28939252
  • Department of Pathology, Yale University School of Medicine, 310 Cedar St, PO Box 208023, New Haven, CT, 06520-8023, USA. · Department of Pathology, Yale University School of Medicine, 310 Cedar St, PO Box 208023, New Haven, CT, 06520-8023, USA. · Department of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA. · Department of Surgery, Yale University School of Medicine, New Haven, CT, USA. · Pubmed 28784153
  • Department of Surgery, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA. · Department of Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA. · Department of Therapeutic Oncology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA. · Department of Surgery, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA. · Pubmed 28766195
  • Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. · MTA TTK Lendület Cancer Biomarker Research Group & Semmelweis University Second Department of Pediatrics, Budapest, Hungary. · Department of Obstetrics and Gynecology, Goethe-University Frankfurt, Frankfurt, Germany. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Pubmed 28428277
  • Yale University School of Medicine; and Yale Cancer Outcomes Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT. · Pubmed 28267392
  • Department of Breast Medical Oncology, Yale University, Yale Cancer Center, New Haven, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science, Inverness, Scotland. · Breast Center, Department of Obstetrics and Gynecology, University of Munich, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Hospital Moinhos de Vento, Porto Alegre, Brazil. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · The Christie/NIHR Clinical Research Facility, Manchester, UK. · Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · Novartis, Cambridge. · Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, USA. · Pubmed 28177460
  • Oncology Experimental Therapeutics, Humanitas Clinical and Research Institute, 20089 Rozzano-Milan, Italy. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Oncology Experimental Therapeutics, Humanitas Clinical and Research Institute, 20089 Rozzano-Milan, Italy. · 2nd Department of Pediatrics, Semmelweis University, H-1094 Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Hungarian Academy of Sciences, H-1117 Budapest, Hungary. · Oncology Experimental Therapeutics, Humanitas Clinical and Research Institute, 20089 Rozzano-Milan, Italy. · Department of Breast Medical Oncology, Yale University, Yale Cancer Center, New Haven, CT 06520, USA. · Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · RNA Interference and Non-Coding RNA Center, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Oncology Experimental Therapeutics, Humanitas Clinical and Research Institute, 20089 Rozzano-Milan, Italy. · Pubmed 28106823
  • Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, Yale University, New Haven, Connecticut. · Yale Cancer Center, New Haven, Connecticut. · Department of Pathology, Yale School of Medicine, Yale University, New Haven, Connecticut. · Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, Yale University, New Haven, Connecticut. · Pubmed 27872098
  • Yale University School of Medicine and Yale Cancer Center, New Haven, Connecticut. · Department of Obstetrics and Gynecology, University Hospital Münster, Germany. · Myriad Genetics Inc., Salt Lake City, Utah. · Yale University School of Medicine and Yale Cancer Center, New Haven, Connecticut. · Pubmed 27601588
2016
  • Oncology Experimental Therapeutics, Istituto di Ricovero e Cura a Carattere Scientifico Humanitas Clinical and Research Institute, Milan, Italy · Oncology Experimental Therapeutics, Istituto di Ricovero e Cura a Carattere Scientifico Humanitas Clinical and Research Institute, Milan, Italy. · Mater Misericordiae University Hospital, Dublin, Ireland. · 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · 2nd Department of Pathology, Semmelweis University, Budapest, Hungary. · Yale Cancer Center, School of Medicine, Yale University, New Haven, Connecticut, USA · Pubmed 27384237
  • Division of Hematology-Oncology, Department of Internal Medicine, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, TX, USA. · SWOG Statistical Center, Seattle, WA, USA. · University of Michigan, Ann Arbor, MI, USA. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Women and Infants Hospital of Rhode Island and Warren Alpert Medical School of Brown University, Providence, RI, USA. · Genentech, Inc., San Francisco, CA, USA. · Mayo Clinic, Jacksonville, FL, USA. · Hematology Oncology Consultants, Inc., Westerville, OH, USA. · Columbus NCI Community Oncology Research Program, Columbus, OH, USA. · Loma Linda University Cancer Center, Loma Linda, CA, USA. · Gibbs Cancer Center and Research Institute/Southeast Clinical Oncology Research (SCOR) Consortium NCORP/Upstate Carolina CCOP (previous), Spartanburg, SC, USA. · Yale University, New Haven, CT, USA. · Arizona Cancer Center, Tucson, AZ, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 27393622
  • Department of Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America. · MTA TTK Lendulet Cancer Biomarker Research Group, Research Center for Natural Sciences, Budapest, Hungary. · 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · Department of Genetics, Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Yale Cancer Center, New Haven, Connecticut, United States of America. · Pubmed 27959926
  • Department of Pathology, Yale School of Medicine, Yale University, 310 Cedar St., PO Box 208023, New Haven, CT, 06520-8023, USA. · Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA. · Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA. · Department of Surgery, Yale School of Medicine, Yale University, New Haven, CT, USA. · Department of Pathology, Yale School of Medicine, Yale University, 310 Cedar St., PO Box 208023, New Haven, CT, 06520-8023, USA. · Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA. · Pubmed 27473061
  • Hannah Dzimitrowicz, Annette Hood, Osama Abdelghany, Christos Hatzis, and Lajos Pusztai, Yale University School of Medicine, New Haven, CT; Michael Berger and Craig Vargo, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH; and Akshara Singareeka Raghavendra, Debu Tripathy, Vicente Valero, and Rashmi Murthy, MD Anderson Cancer Center, Houston, TX. · Pubmed 27298406
  • Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT 06520, USA. · Radiology, Yale Cancer Center, Yale School of Medicine, New Haven, CT 06520, USA. · Pathology, Yale Cancer Center, Yale School of Medicine, New Haven, CT 06520, USA. · Pubmed 26980737
  • Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Department of Obstetrics and Gynecology, Goethe-University Frankfurt, Frankfurt am Main, Germany. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. · Pubmed 26867935
  • Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut. · Yale Cancer Center Genetics and Genomics Program, Yale University School of Medicine, New Haven, Connecticut. · Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut. Department of Biomedical Engineering, Yale University, New Haven, Connecticut. · Institute for RNA Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Humanitas Clinical and Research Institute, Rozzano, Milan, Italy. · Department of Biomedical Engineering, Yale University, New Haven, Connecticut. · Institute for RNA Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Pubmed 26676753
  • Department of Internal Medicine, Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Internal Medicine, Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut. · Department of Surgery, Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut. · Pubmed 26286912
  • Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut. · Pubmed 28212357
  • Tara Sanft and Lajos Pusztai, Yale University School of Medicine, New Haven, CT. · Pubmed 27551119
2015
  • Department of Breast and Gynaecological Surgery, Curie Institute, Versailles-St-Quentin-en-Yvelines University, Versailles, France. · UMR3664: "Dynamic of the cell nucleus" Unit, National Center for scientific Research (CNRS), Curie Institute, Paris, France. · UMR 981: "Predictive biomarkers and new molecular therapeutic strategies in cancer", Integrated Research Cancer Institute in Villejuif, Paris, France. · Yale Cancer Center Genetics and Genomics Program, Yale School of Medicine, New Haven, CT, U.S.A. · Department of Breast and Gynaecological Surgery, Curie Institute, Versailles-St-Quentin-en-Yvelines University, Versailles, France EA 7285: "Clinics risks and security in women's health and perinatal health", Versailles-St-Quentin-en-Yvelines University, Versailles, France · Pubmed 26408675
  • Brigid K. Killelea, Brandon Hayse, Sarah Mougalian, Nina R. Horowitz, Anees B. Chagpar, Lajos Pusztai, and Donald R. Lannin, Yale University School of Medicine; Brigid K. Killelea, Sarah Mougalian, Nina R. Horowitz, Anees B. Chagpar, Lajos Pusztai, and Donald R. Lannin, Yale Comprehensive Cancer Center; and Vicky Q. Yang and Shi-Yi Wang, Yale University School of Public Health, New Haven, CT. · Brigid K. Killelea, Brandon Hayse, Sarah Mougalian, Nina R. Horowitz, Anees B. Chagpar, Lajos Pusztai, and Donald R. Lannin, Yale University School of Medicine; Brigid K. Killelea, Sarah Mougalian, Nina R. Horowitz, Anees B. Chagpar, Lajos Pusztai, and Donald R. Lannin, Yale Comprehensive Cancer Center; and Vicky Q. Yang and Shi-Yi Wang, Yale University School of Public Health, New Haven, CT. · Pubmed 26598753
  • Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · BioTheranostics, Inc., 9640 Towne Centre Drive, Suite 200, San Diego, CA, 92121, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · BioTheranostics, Inc., 9640 Towne Centre Drive, Suite 200, San Diego, CA, 92121, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Pubmed 26578401
  • Yale Cancer Center, Yale School of Medicine, Section of Oncology, 300 George Street, New Haven, CT 06511, USA. · Pubmed 26552957
  • MTA TTK Lendület Cancer Biomarker Research Group, Research Centre for Natural Sciences, Magyar tudósok körútja 2, Budapest, H-1117, Hungary. · 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA. · MTA TTK Lendület Cancer Biomarker Research Group, Research Centre for Natural Sciences, Magyar tudósok körútja 2, Budapest, H-1117, Hungary. · 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · MTA-SE Pediatrics and Nephrology Research Group, Budapest, Hungary. · Pubmed 26474971
  • Department of Breast Medical Oncology of Yale University, New Haven, CT, USA. · Molecular, Cellular and Developmental Biology of Yale University, New Haven, CT, USA. · Department of Quantitative Sciences of the University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Experimental Therapeutics of the University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Department of Pharmacology of Yale University, New Haven, CT, USA. · Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY, USA. · Foundation Medicine, Cambridge, MA, USA. · Pathology of the University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 26420498
  • Department of Gynecology and Obstetrics, Lariboisiere Hospital, AP-HP, 2 Rue Ambroise-Pare, Paris, France. · University Denis Diderot, Paris, France. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgery, Institut Curie, Saint-Cloud, Paris, France. · Department of Gynecology and Obstetrics, Tenon Hospital, Paris, France. · University Pierre and Marie Curie, Paris, France. · Versailles Saint-Quentin-en-Yvelines University, Versailles, France. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, Georges Francois Leclerc Cancer Center, Dijon, France. · Breast Medical Oncology Program, NYU Cancer Institute, New York, NY, USA. · Section of Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA. · Pubmed 26393887
  • Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. · Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, USA. · Centrum Onkologii, Warsaw, Poland. · Department of Medicine, Samsung Medical Center, Seoul, Republic of Korea. · Oncologia Medica, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Taipei-Veterans General Hospital, National Yang-Ming University, Taipei. · Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan. · Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, Valencia, Spain. · Fondazione Michelangelo, Milan, Italy. · Hospital Reina Sofia, Córdoba, Spain. · Division of Medical Oncology, Seoul National University Hospital Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. · Centre des maladies du sein, Hôpital du Saint-Sacrement, CHU de Québec, Québec, Canada. · Hospital Ernesto Dornelles, Porto Alegre, Brazil. · NN Petrov Research Institute of Oncology, St Petersburg, Russia. · Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy · Pubmed 26387142
  • Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Department of Surgery, Curie Institute, Paris, France. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26275950
  • Departments of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, United States of America. · Pubmed 26136146
  • U.O. di Patologia Mammaria-Breast Cancer Unit, U.S. Terapia Molecolare e Farmacogenomica, AO-Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Centre for Research on Health and Social Care Management (CeRGAS), Bocconi University, Via Roentgen 1, Milan, Italy. · Yale Cancer Center, Yale School of Medicine, New Haven, CT, United States. · Translational Breast Cancer Genomics and Therapeutics Lab, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Centre Hospitalier Universitaire du Sart Tilman Liege and Liege University, Liège, Belgium. · U.O. di Patologia Mammaria-Breast Cancer Unit, U.S. Terapia Molecolare e Farmacogenomica, AO-Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Department of Policy Analysis and Public Management, Bocconi University, Via Roentgen 1, Milan, Italy. · Pubmed 26044370
  • : Department of Pathology (DECH, KAS, DLR) and Medical Oncology (LP), Yale University School of Medicine, New Haven, CT; Attikon University Hospital, Athens, Greece (AP); Translational Research Section, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece (KTK); Department of Medical Oncology, "Papageorgiou" Hospital (KTK, GF), Department of Pathology (VK), and Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research (VK, GF), Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece. · : Department of Pathology (DECH, KAS, DLR) and Medical Oncology (LP), Yale University School of Medicine, New Haven, CT; Attikon University Hospital, Athens, Greece (AP); Translational Research Section, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece (KTK); Department of Medical Oncology, "Papageorgiou" Hospital (KTK, GF), Department of Pathology (VK), and Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research (VK, GF), Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece. · Pubmed 25991002
  • Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · Department of Surgery, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · Department of Medicine, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · Pubmed 25902916
  • Department of Surgery, Yale University School of Medicine, and Yale Comprehensive Cancer Center, New Haven, CT 06520. Electronic address: · Department of Epidemiology, Yale University School of Medicine, and Yale Comprehensive Cancer Center, New Haven, CT 06520. · Department of Medicine, Yale University School of Medicine, and Yale Comprehensive Cancer Center, New Haven, CT 06520. · Department of Surgery, Yale University School of Medicine, and Yale Comprehensive Cancer Center, New Haven, CT 06520. · Pubmed 25868410
  • Yale University School of Public Health; and Yale University School of Medicine, New Haven, CT. · Yale University School of Public Health; and Yale University School of Medicine, New Haven, CT · Pubmed 25784577
  • Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · Cell Signaling Technology, Inc., Danvers, Massachusetts. · Department of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut. · Department of Surgery, Yale University School of Medicine, New Haven, Connecticut. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · Pubmed 25527356
  • Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science (Scotland) Ltd., Inverness-shire, Scotland. · Clinical Research, Monogram Biosciences, Inc., South San Francisco, California. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Center, Department of Obstetrics and Gynecology, and CCC LMU, University of Munich, Munich, Germany. · Genetics and Genomics Program, Yale School of Medicine, New Haven, Connecticut. · Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania. · Department of Gynecology and Midwifery, University Hospital Kiel, Kiel, Germany. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25467182
2014
  • Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · New York University Langone Medical Center, New York University, New York, New York. · Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Bristol-Myers Squibb Inc., New York, New York. · Pubmed 25172932
  • Department of Breast Medical Oncology Department of Systems Biology · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology. · Genenetech, San Francisco. · Departments of Biostatistics. · Clinical Cancer Prevention. · Radiology. · Pathology, The University of Texas MD Anderson Cancer Center, Houston. · Division of Hematology-Oncology, Yale University, New Haven. · Department of Systems Biology. · Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 24669015
  • 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [4] Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] INSERM, U848, Villejuif, France. · 1] INSERM, U848, Villejuif, France. [2] Equipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [3] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Regina Elena National Cancer Institute, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Transgene S.A., Illkirch-Graffenstaden, France. · Laboratory for Genomics and Immunoregulation, Life and Medical Sciences (LIMES), University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology, University Hospital Bonn, Bonn, Germany. · Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] SIB-Swiss Institute of Bioinformatics, Lausanne, Switzerland. [2] National Center of Competence in Research (NCCR) Molecular Oncology, Institut Suisse de Recherche Expérimentale sur le Cancer (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. [3] Departement de Formation et Recherche, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Department of Pathology, Centre Claudius Regaud, Toulouse, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. [4] Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Yale School of Medicine, New Haven, Connecticut, USA. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Pathology, Jean Perrin Center, EA 4677 ERTICa, University of Auvergne, Clermont-Ferrand, France. · 1] Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. [2] INSERM, CRI-866 Faculty of Medicine, Dijon, France. [3] University of Burgundy, Dijon, France. · Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · San Raffaele University and Scientific Institute, Milan, Italy. · 1] Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts, USA. [2] Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Transgene S.A., Illkirch-Graffenstaden, France. · CNRS UMR5235, University Montpellier II, Place Eugène Bataillon, Montpellier, France. · Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA. · Queensland Institute of Medical Research, Herston, Queensland, Australia. · 1] Queensland Institute of Medical Research, Herston, Queensland, Australia. [2] School of Medicine, The University of Queensland, Herston, Queensland, Australia. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [4] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. [5] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U848, Villejuif, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. [4] Metabolomics Platform, Gustave Roussy Cancer Campus, Villejuif, France. [5] Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · Pubmed 25344738
  • Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Pubmed 24957076
  • Authors' Affiliations: Departments of Pathology and Medical Oncology, Yale School of Medicine, New Haven, Connecticut; and Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, Ohio · Authors' Affiliations: Departments of Pathology and Medical Oncology, Yale School of Medicine, New Haven, Connecticut; and Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, Ohio. · Pubmed 24647569
  • Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. · Department of Pathology, UT M.D. Anderson Cancer Center, P.O. Box 85, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Department of Bioinformatics and Computational Biology, UT M.D. Anderson Cancer Center, P.O. Box 301402, Houston, TX 77230, USA. · Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. Electronic address: · Pubmed 24602449
  • Research Laboratory of Pediatrics and Nephrology, Hungarian Academy of Sciences, Budapest, Hungary; Oncogenomic Research Group, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato 59100, Italy. · Department of Biochemistry and INSERM U944, University Rene Diderot, Paris 7, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France. · Pathobiochemistry Research Group of Hungarian Academy of Sciences, Semmelweis University, Department of Medicinal Chemistry, 1444, Bp. 8, POB 260, Hungary; Vichem Chemie Research Ltd, 1022, Herman Otto 15, Budapest, Hungary. · Vichem Chemie Research Ltd, 1022, Herman Otto 15, Budapest, Hungary; Department of Pharmaceutical Chemistry, Semmelweis University, Budapest, Hungary. · Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan. · Breast Cancer Translational Laboratory, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium. · Division of Medical Oncology, San Raffaele - Scientific Institute, Milan, Italy. · The Breakthrough Breast Cancer Research Center, Institute of Cancer Research, London, UK. · Department of Medical Oncology, Institut National de la Santé et de la Recherche Médicale Unit U981, Institut Gustave Roussy, Villejuif, France. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medical Oncology Unit Sandro Pitigliani, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Yale Cancer Center, New Haven, CT, USA. · Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato 59100, Italy. Electronic address: · Pubmed 24462521
  • Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, 450 Brookline Ave. Boston, MA 02215. · Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215. · Foundation Medicine, One Kendall Sq. Cambridge, MA 02139. · Departments of Investigational Cancer Therapeutics, Surgical Oncology, The University of MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030. · Departments of Systems Biology, and Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030. · Fundacion de Investigacion INCLIVA - Institute for Health Reseearch, Valencia, Spain. · Departments of Hematology-Oncology, Hospital Clinico Universitario de Valencia, Valencia, Spain. · Jefferson Breast Care Center, Kimmel Cancer Center, Thomas Jefferson University, 925 Chestnut St. Philadelphia, PA 19107. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 2220 Pierce Ave, Nashville, TN 37232. · Teva Pharmaceuticals, 5 Basel St. Petach Tikva, Israel 49131. · Oncology Division, Tel Aviv Sourasky Medical Center , 6 Weizmann St. Tel Aviv 64239, Israel. · Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave. Boston MA 02215. · Breast Medical Oncology Program, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave. Boston MA 02215. · Section of Breast Medical Oncology, Yale School of Medicine, New Haven, South Frontage Rd and Park St. CN, 06510. · Pubmed 24398047
2017
  • W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Xian Yu, Ya Zhang, Maheshwari Ramineni, Kelly Hunt, Thomas A. Buchholz, Vicente Valero, Aman U. Buzdar, Wei Yang, Abenaa M. Brewster, Stacy Moulder, and Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston; Andrew Walls, Uniformed Services University of the Health Sciences, San Antonio, TX; Mei Liu, The General Hospital of People's Liberation Army, Beijing, China; Alex Bousamra, Allegheny General Hospital, Pittsburgh, PA; Bruno Sinn, Charite-Universitatsmedizin, Berlin, Germany; and Lajos Pusztai and Christos Hatzis, Yale University School of Medicine, New Haven, CT. · Pubmed 28135148
  • *Department of Surgery, Yale University †Yale Cancer Center ‡Yale Center for Outcomes Public Policy and Effectiveness Research §Department of Surgery, Thomas Jefferson University ¶Yale-New Haven Hospital ||Yale Center for Analytical Sciences **Department of Pathology, Yale University ††Department of Medicine, Yale University. · Pubmed 27192352
2016
  • Rita Nanda, University of Chicago, Chicago, IL; Laura Q.M. Chow, University of Washington, Seattle, WA; E. Claire Dees, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Raanan Berger, Sheba Medical Center, Tel Hashomer; Ravit Geva, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Lajos Pusztai, Yale University School of Medicine, New Haven, CT; Kumudu Pathiraja, Gursel Aktan, Jonathan D. Cheng, and Vassiliki Karantza, Merck & Co., Kenilworth, NJ; and Laurence Buisseret, Université Libre de Bruxelles, Bruxelles, Belgium. · Rita Nanda, University of Chicago, Chicago, IL; Laura Q.M. Chow, University of Washington, Seattle, WA; E. Claire Dees, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Raanan Berger, Sheba Medical Center, Tel Hashomer; Ravit Geva, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Lajos Pusztai, Yale University School of Medicine, New Haven, CT; Kumudu Pathiraja, Gursel Aktan, Jonathan D. Cheng, and Vassiliki Karantza, Merck & Co., Kenilworth, NJ; and Laurence Buisseret, Université Libre de Bruxelles, Bruxelles, Belgium. · Pubmed 27138582
  • aDepartmentof Medical Oncology, Yale Cancer Center, Yale School of Medicine bDepartment of Social and Behavioral Sciences, Yale School of Public Health, New Haven, Connecticut, USA cDepartment of Medical Oncology, Marmara University Pendik Training and Research Hospital, Marmara University School of Medicine, Ust Kaynarca, Istanbul, Turkey. · Pubmed 25642790
2015
  • From the Departments of Surgery (A.B.C., B.K.K., M.B., K.S., D.R.L., N.R.H.), Pathology (V.B., M.H.), and Medicine (L.P.), Yale Cancer Center (A.B.C., B.K.K., M.B., K.S., F.L., X.Y., D.R.L., L.P., N.R.H.), and Yale Center for Analytical Sciences (F.L., X.Y.), Yale University School of Medicine, New Haven, CT; and the Department of Surgery, Thomas Jefferson University, Philadelphia (T.N.T.). · Pubmed 26028131
  • Yale University School of Medicine, New Haven, CT, USA, · Pubmed 25651779
2014
  • Department of Internal Medicine, Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut, USA. · Pubmed 25294321
  • Yale University School of Medicine, New Haven, Connecticut, USA; Foundation Medicine, Cambridge, Massachusetts, USA; MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 24710307
  • Yale Cancer Center, Yale School of Medicine, Yale University, 333 Cedar St, PO Box 208032, New Haven, CT, 06520, USA. · Pubmed 24619174
  • Authors' Affiliations: Departments of Breast Medical Oncology, Biostatistics, Pathology, Systems Biology, and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Division of Hematology-Oncology, Yale University, New Haven, Connecticut. · Pubmed 24296856
2013
  • Yale University School of Medicine, Yale Cancer Center, Section of Breast Medical Oncology, 333 Cedar St, PO Box 208032, New Haven, CT 06520-8032, USA. Electronic address: · Pubmed 24074799
Probable:    University of Texas Houston   Contact    
2016
  • Hannah Dzimitrowicz, Annette Hood, Osama Abdelghany, Christos Hatzis, and Lajos Pusztai, Yale University School of Medicine, New Haven, CT; Michael Berger and Craig Vargo, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH; and Akshara Singareeka Raghavendra, Debu Tripathy, Vicente Valero, and Rashmi Murthy, MD Anderson Cancer Center, Houston, TX. · Pubmed 27298406
2015
  • 1] Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. [2] Graduate School of Biomedical Sciences, The University of Texas at Houston, Houston, TX 77030, USA. · Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · 1] Graduate School of Biomedical Sciences, The University of Texas at Houston, Houston, TX 77030, USA. [2] Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Methodist Hospital Research Institute, Houston, TX 77030, USA. · Department of Endocrinology Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · 1] Department of Endocrinology Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. [2] Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 26179207
2014
  • Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Pubmed 24957076
  • 1] Breast Cancer Translational Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [2] Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [3] Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo, Japan. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo, Japan. · 1] Breast Cancer Translational Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [2] Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Pubmed 23376849
2011
  • Department of Breast Medical Oncology, UT MD Anderson Cancer Center, P.O. Box 301439, Houston, TX 77230-1439, USA. · Pubmed 20464478
2010
  • Department of Breast Medical Oncology, M. D. Anderson Cancer Center, Houston, Tx 77230-1439, USA. · Pubmed 21041379
2009
  • Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA. · Pubmed 20030862
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, PO Box 301439, Houston, TX 77230-1439, USA. · Pubmed 19667268
2017
  • W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Xian Yu, Ya Zhang, Maheshwari Ramineni, Kelly Hunt, Thomas A. Buchholz, Vicente Valero, Aman U. Buzdar, Wei Yang, Abenaa M. Brewster, Stacy Moulder, and Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston; Andrew Walls, Uniformed Services University of the Health Sciences, San Antonio, TX; Mei Liu, The General Hospital of People's Liberation Army, Beijing, China; Alex Bousamra, Allegheny General Hospital, Pittsburgh, PA; Bruno Sinn, Charite-Universitatsmedizin, Berlin, Germany; and Lajos Pusztai and Christos Hatzis, Yale University School of Medicine, New Haven, CT. · Pubmed 28135148
2016
  • From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California; University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago; University of Pennsylvania, Philadelphia (A.D.); Gemini Group, Ann Arbor, MI (J.P.); University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas; University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota; Swedish Medical Center, Seattle (H.G.K.); Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.); University of Kansas, Lawrence (Q.J.K.); University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona; Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.); University of Denver, Denver (A.D.E.); Inova Fairfax Hospital, Falls Church, VA (K.K.E.); and Emory University, Atlanta (W.C.W.). · Pubmed 27406347
  • From University of California, San Francisco (J.W.P., C.Y., L.J.V., N.M.H., M.B.B., A.J.C., M.M., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California, San Diego, San Diego (A.M.W., R.S., T.H.), and University of Southern California, Los Angeles (D.T.) - all in California; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.); University of Minnesota, Minneapolis (D.Y., T.C.H.), and Mayo Clinic, Rochester (J.C.B.) - both in Minnesota; M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), University of Texas Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas; Gemini Group, Ann Arbor, MI (J.P.); University of Pennsylvania, Philadelphia (A.D.); Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.); Swedish Medical Center, Seattle (H.G.K.); University of Chicago (R.N.) and Loyola University (K.S.A.) - both in Chicago; Inova Fairfax Hospital, Falls Church, VA (K.K.E.); University of Denver, Denver (A.D.E.); Mayo Clinic, Scottsdale (D.W.N.), and University of Arizona, Tucson (J.E.L., R.K.V.) - both in Arizona; University of Kansas, Lawrence (Q.J.K.); and Emory University, Atlanta (W.C.W.). · Pubmed 27406346
2014
  • Yale University School of Medicine, New Haven, Connecticut, USA; Foundation Medicine, Cambridge, Massachusetts, USA; MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 24710307
  • Authors' Affiliations: Departments of Breast Medical Oncology, Biostatistics, Pathology, Systems Biology, and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Division of Hematology-Oncology, Yale University, New Haven, Connecticut. · Pubmed 24296856
2013
  • Authors' Affiliations: Department of Breast Medical Oncology, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Departments of Molecular and Cellular Oncology, Pathology, Radiation Oncology, and Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Tolero Pharmaceuticals, Inc., Salt Lake City, Utah; and Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan. · Pubmed 24014597
  • Departmentsof Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23337751
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 23299541
  • Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 23242617
  • Department of Surgical Oncology, Unit 1484, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77030, USA. · Pubmed 23208590
2012
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, PO Box 301439, Houston, TX 77230-1439, USA. · Pubmed 22890751
  • Department of Radiation Oncology, 1515 Holcombe Blvd,, University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA. · Pubmed 22559056
  • Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22370716
  • Department of Systems Biology - Unit 950, The University of Texas MD Anderson Cancer Center, 7435 Fannin Street, Houston, TX 77054, USA. · Pubmed 22343619
  • The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA. · Pubmed 22291085
  • Departments of Breast Medical Oncology, Systems Biology, Biostatistics, Surgical Oncology, and Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22235097
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21823108
2011
  • Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 22132775
  • Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77230-1439, USA. · Pubmed 22043042
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, TX 77030-4009, USA. · Pubmed 21900106
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77230-1439, USA. · Pubmed 21833625
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., 77030, Houston, TX, USA. · Pubmed 21710134
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1439, USA. · Pubmed 21248301
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77230-1439, USA. · Pubmed 21191116
  • Breast Cancer Translational Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21153052
  • Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 21061075
  • Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 20939012
2010
  • Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, United States. · Pubmed 20739212
  • Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA. · Pubmed 21172090
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77230-1439, USA. · Pubmed 20829329
  • Department of Breast Medical Oncology, Unit 1354, The University of Texas M. D. Anderson Cancer Center, PO Box 301439, Houston,TX 77230-1439, USA. · Pubmed 20805453
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 20697068
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 20665886
  • Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20665494
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20423993
  • Department of Breast Medical Oncology, The University of Texas,M.D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 20421265
  • FACP, Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Unit 1354, Houston, TX 77030, USA. · Pubmed 20308667
  • Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 20231683
  • Department of Breast Medical Oncology, Unit 1354, The University of Texas M. D. Anderson Cancer Center, P.O. Box 301439, Houston, TX 77230-1439, USA. · Pubmed 20024612
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, BO Box 301439, Houston, TX 77030-1439, USA. · Pubmed 19603265
2009
  • Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA. · Pubmed 19887608
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77039, USA. · Pubmed 19596702
Probable:    Ohio State University   Contact    
2016
  • Hannah Dzimitrowicz, Annette Hood, Osama Abdelghany, Christos Hatzis, and Lajos Pusztai, Yale University School of Medicine, New Haven, CT; Michael Berger and Craig Vargo, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH; and Akshara Singareeka Raghavendra, Debu Tripathy, Vicente Valero, and Rashmi Murthy, MD Anderson Cancer Center, Houston, TX. · Pubmed 27298406
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 159 total) written by Lajos Pusztai about Breast Neoplasms:

  • Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR. 2018
  • New Therapeutic Strategies for Triple-Negative Breast Cancer. 2017
  • Impacts of Early Guideline-Directed 21-Gene Recurrence Score Testing on Adjuvant Therapy Decision Making. 2017
  • Discussion of: "Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?" 2017
  • Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer. 2017
  • Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer. 2017
  • Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer? 2017
  • Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance. 2017
  • Association of LN Evaluation with Survival in Women Aged 70 Years or Older With Clinically Node-Negative Hormone Receptor Positive Breast Cancer. 2017
  • Immune Gene Expression Is Associated with Genomic Aberrations in Breast Cancer. 2017
Show List of Full Article Records
Google Searches

Learn more about Lajos Pusztai using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Yale University
University of Texas Houston
Ohio State University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Yale University
2018
  • Department of Medical, Surgery and Health Sciences, University of Trieste, Piazza Ospitale 1, Trieste, 34129, Italy. · UO Multidisciplinare di Patologia Mammaria e Ricerca Traslazionale, ASST di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Peter MacCallum Cancer Centre, Moorabbin Campus, 865 Centre Rd, Bentleigh East, VIC, 3165, Australia. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA. · Department of Surgical Oncology, Institut Curie-René Huguenin, 35 rue Dailly, St Cloud, France. · Department of Obstetrics and Gynaecology, Tenon University Hospital, Paris, France. · Pubmed 29344722
2017
  • Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT. · Pubmed 29048991
  • Yale University School of Medicine, New Haven, CT, USA. Electronic address: · Yale University School of Medicine, New Haven, CT, USA. · Pubmed 28987415
  • Department of Breast Medical Oncology. · Department of Biostatistics. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Breast and Endocrine Surgery, Okayama University, Okayama, Japan. · Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, USA. · Pubmed 28961844
  • Foundation Medicine, Inc., Cambridge. · Avera Cancer Institute, Sioux Falls. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas. · Sarah Cannon Research Institute, Nashville. · Eastchester Center for Cancer Care, Bronx. · Sutter Medical Group of the Redwoods, Santa Rosa. · Division of Medical Oncology, Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick. · Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore. · Weill Cornell Breast Center, Weill Cornell Medicine, New York. · Tufts University Medical Center, Boston. · Department of Breast Medical Oncology, Yale University, Yale Cancer Center, New Haven. · Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, USA. · Pubmed 28945887
  • Department of Surgery, Yale University School of Medicine, New Haven, CT, USA. Electronic address: · Department of Surgery, Yale University School of Medicine, New Haven, CT, USA. · Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, USA. · Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA. · Pubmed 28939252
  • Department of Pathology, Yale University School of Medicine, 310 Cedar St, PO Box 208023, New Haven, CT, 06520-8023, USA. · Department of Pathology, Yale University School of Medicine, 310 Cedar St, PO Box 208023, New Haven, CT, 06520-8023, USA. · Department of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA. · Department of Surgery, Yale University School of Medicine, New Haven, CT, USA. · Pubmed 28784153
  • Department of Surgery, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA. · Department of Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA. · Department of Therapeutic Oncology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA. · Department of Surgery, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA. · Pubmed 28766195
  • Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. · MTA TTK Lendület Cancer Biomarker Research Group & Semmelweis University Second Department of Pediatrics, Budapest, Hungary. · Department of Obstetrics and Gynecology, Goethe-University Frankfurt, Frankfurt, Germany. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Pubmed 28428277
  • Yale University School of Medicine; and Yale Cancer Outcomes Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT. · Pubmed 28267392
  • Department of Breast Medical Oncology, Yale University, Yale Cancer Center, New Haven, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science, Inverness, Scotland. · Breast Center, Department of Obstetrics and Gynecology, University of Munich, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Hospital Moinhos de Vento, Porto Alegre, Brazil. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · The Christie/NIHR Clinical Research Facility, Manchester, UK. · Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · Novartis, Cambridge. · Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, USA. · Pubmed 28177460
  • Oncology Experimental Therapeutics, Humanitas Clinical and Research Institute, 20089 Rozzano-Milan, Italy. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Oncology Experimental Therapeutics, Humanitas Clinical and Research Institute, 20089 Rozzano-Milan, Italy. · 2nd Department of Pediatrics, Semmelweis University, H-1094 Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Hungarian Academy of Sciences, H-1117 Budapest, Hungary. · Oncology Experimental Therapeutics, Humanitas Clinical and Research Institute, 20089 Rozzano-Milan, Italy. · Department of Breast Medical Oncology, Yale University, Yale Cancer Center, New Haven, CT 06520, USA. · Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · RNA Interference and Non-Coding RNA Center, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Oncology Experimental Therapeutics, Humanitas Clinical and Research Institute, 20089 Rozzano-Milan, Italy. · Pubmed 28106823
  • Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, Yale University, New Haven, Connecticut. · Yale Cancer Center, New Haven, Connecticut. · Department of Pathology, Yale School of Medicine, Yale University, New Haven, Connecticut. · Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, Yale University, New Haven, Connecticut. · Pubmed 27872098
  • Yale University School of Medicine and Yale Cancer Center, New Haven, Connecticut. · Department of Obstetrics and Gynecology, University Hospital Münster, Germany. · Myriad Genetics Inc., Salt Lake City, Utah. · Yale University School of Medicine and Yale Cancer Center, New Haven, Connecticut. · Pubmed 27601588
2016
  • Oncology Experimental Therapeutics, Istituto di Ricovero e Cura a Carattere Scientifico Humanitas Clinical and Research Institute, Milan, Italy · Oncology Experimental Therapeutics, Istituto di Ricovero e Cura a Carattere Scientifico Humanitas Clinical and Research Institute, Milan, Italy. · Mater Misericordiae University Hospital, Dublin, Ireland. · 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · 2nd Department of Pathology, Semmelweis University, Budapest, Hungary. · Yale Cancer Center, School of Medicine, Yale University, New Haven, Connecticut, USA · Pubmed 27384237
  • Division of Hematology-Oncology, Department of Internal Medicine, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, TX, USA. · SWOG Statistical Center, Seattle, WA, USA. · University of Michigan, Ann Arbor, MI, USA. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Women and Infants Hospital of Rhode Island and Warren Alpert Medical School of Brown University, Providence, RI, USA. · Genentech, Inc., San Francisco, CA, USA. · Mayo Clinic, Jacksonville, FL, USA. · Hematology Oncology Consultants, Inc., Westerville, OH, USA. · Columbus NCI Community Oncology Research Program, Columbus, OH, USA. · Loma Linda University Cancer Center, Loma Linda, CA, USA. · Gibbs Cancer Center and Research Institute/Southeast Clinical Oncology Research (SCOR) Consortium NCORP/Upstate Carolina CCOP (previous), Spartanburg, SC, USA. · Yale University, New Haven, CT, USA. · Arizona Cancer Center, Tucson, AZ, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 27393622
  • Department of Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America. · MTA TTK Lendulet Cancer Biomarker Research Group, Research Center for Natural Sciences, Budapest, Hungary. · 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · Department of Genetics, Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Yale Cancer Center, New Haven, Connecticut, United States of America. · Pubmed 27959926
  • Department of Pathology, Yale School of Medicine, Yale University, 310 Cedar St., PO Box 208023, New Haven, CT, 06520-8023, USA. · Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA. · Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA. · Department of Surgery, Yale School of Medicine, Yale University, New Haven, CT, USA. · Department of Pathology, Yale School of Medicine, Yale University, 310 Cedar St., PO Box 208023, New Haven, CT, 06520-8023, USA. · Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA. · Pubmed 27473061
  • Hannah Dzimitrowicz, Annette Hood, Osama Abdelghany, Christos Hatzis, and Lajos Pusztai, Yale University School of Medicine, New Haven, CT; Michael Berger and Craig Vargo, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH; and Akshara Singareeka Raghavendra, Debu Tripathy, Vicente Valero, and Rashmi Murthy, MD Anderson Cancer Center, Houston, TX. · Pubmed 27298406
  • Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT 06520, USA. · Radiology, Yale Cancer Center, Yale School of Medicine, New Haven, CT 06520, USA. · Pathology, Yale Cancer Center, Yale School of Medicine, New Haven, CT 06520, USA. · Pubmed 26980737
  • Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Department of Obstetrics and Gynecology, Goethe-University Frankfurt, Frankfurt am Main, Germany. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. · Pubmed 26867935
  • Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut. · Yale Cancer Center Genetics and Genomics Program, Yale University School of Medicine, New Haven, Connecticut. · Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut. Department of Biomedical Engineering, Yale University, New Haven, Connecticut. · Institute for RNA Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Humanitas Clinical and Research Institute, Rozzano, Milan, Italy. · Department of Biomedical Engineering, Yale University, New Haven, Connecticut. · Institute for RNA Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Pubmed 26676753
  • Department of Internal Medicine, Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Internal Medicine, Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut. · Department of Surgery, Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut. · Pubmed 26286912
  • Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut. · Pubmed 28212357
  • Tara Sanft and Lajos Pusztai, Yale University School of Medicine, New Haven, CT. · Pubmed 27551119
2015
  • Department of Breast and Gynaecological Surgery, Curie Institute, Versailles-St-Quentin-en-Yvelines University, Versailles, France. · UMR3664: "Dynamic of the cell nucleus" Unit, National Center for scientific Research (CNRS), Curie Institute, Paris, France. · UMR 981: "Predictive biomarkers and new molecular therapeutic strategies in cancer", Integrated Research Cancer Institute in Villejuif, Paris, France. · Yale Cancer Center Genetics and Genomics Program, Yale School of Medicine, New Haven, CT, U.S.A. · Department of Breast and Gynaecological Surgery, Curie Institute, Versailles-St-Quentin-en-Yvelines University, Versailles, France EA 7285: "Clinics risks and security in women's health and perinatal health", Versailles-St-Quentin-en-Yvelines University, Versailles, France · Pubmed 26408675
  • Brigid K. Killelea, Brandon Hayse, Sarah Mougalian, Nina R. Horowitz, Anees B. Chagpar, Lajos Pusztai, and Donald R. Lannin, Yale University School of Medicine; Brigid K. Killelea, Sarah Mougalian, Nina R. Horowitz, Anees B. Chagpar, Lajos Pusztai, and Donald R. Lannin, Yale Comprehensive Cancer Center; and Vicky Q. Yang and Shi-Yi Wang, Yale University School of Public Health, New Haven, CT. · Brigid K. Killelea, Brandon Hayse, Sarah Mougalian, Nina R. Horowitz, Anees B. Chagpar, Lajos Pusztai, and Donald R. Lannin, Yale University School of Medicine; Brigid K. Killelea, Sarah Mougalian, Nina R. Horowitz, Anees B. Chagpar, Lajos Pusztai, and Donald R. Lannin, Yale Comprehensive Cancer Center; and Vicky Q. Yang and Shi-Yi Wang, Yale University School of Public Health, New Haven, CT. · Pubmed 26598753
  • Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · BioTheranostics, Inc., 9640 Towne Centre Drive, Suite 200, San Diego, CA, 92121, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · BioTheranostics, Inc., 9640 Towne Centre Drive, Suite 200, San Diego, CA, 92121, USA. · Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, PO Box 208032, 333 Cedar St, New Haven, CT, 06520-8032, USA. · Pubmed 26578401
  • Yale Cancer Center, Yale School of Medicine, Section of Oncology, 300 George Street, New Haven, CT 06511, USA. · Pubmed 26552957
  • MTA TTK Lendület Cancer Biomarker Research Group, Research Centre for Natural Sciences, Magyar tudósok körútja 2, Budapest, H-1117, Hungary. · 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA. · MTA TTK Lendület Cancer Biomarker Research Group, Research Centre for Natural Sciences, Magyar tudósok körútja 2, Budapest, H-1117, Hungary. · 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · MTA-SE Pediatrics and Nephrology Research Group, Budapest, Hungary. · Pubmed 26474971
  • Department of Breast Medical Oncology of Yale University, New Haven, CT, USA. · Molecular, Cellular and Developmental Biology of Yale University, New Haven, CT, USA. · Department of Quantitative Sciences of the University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Experimental Therapeutics of the University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Department of Pharmacology of Yale University, New Haven, CT, USA. · Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY, USA. · Foundation Medicine, Cambridge, MA, USA. · Pathology of the University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 26420498
  • Department of Gynecology and Obstetrics, Lariboisiere Hospital, AP-HP, 2 Rue Ambroise-Pare, Paris, France. · University Denis Diderot, Paris, France. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgery, Institut Curie, Saint-Cloud, Paris, France. · Department of Gynecology and Obstetrics, Tenon Hospital, Paris, France. · University Pierre and Marie Curie, Paris, France. · Versailles Saint-Quentin-en-Yvelines University, Versailles, France. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, Georges Francois Leclerc Cancer Center, Dijon, France. · Breast Medical Oncology Program, NYU Cancer Institute, New York, NY, USA. · Section of Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA. · Pubmed 26393887
  • Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. · Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, USA. · Centrum Onkologii, Warsaw, Poland. · Department of Medicine, Samsung Medical Center, Seoul, Republic of Korea. · Oncologia Medica, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Taipei-Veterans General Hospital, National Yang-Ming University, Taipei. · Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan. · Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, Valencia, Spain. · Fondazione Michelangelo, Milan, Italy. · Hospital Reina Sofia, Córdoba, Spain. · Division of Medical Oncology, Seoul National University Hospital Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. · Centre des maladies du sein, Hôpital du Saint-Sacrement, CHU de Québec, Québec, Canada. · Hospital Ernesto Dornelles, Porto Alegre, Brazil. · NN Petrov Research Institute of Oncology, St Petersburg, Russia. · Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy · Pubmed 26387142
  • Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Department of Surgery, Curie Institute, Paris, France. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26275950
  • Departments of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, United States of America. · Pubmed 26136146
  • U.O. di Patologia Mammaria-Breast Cancer Unit, U.S. Terapia Molecolare e Farmacogenomica, AO-Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Centre for Research on Health and Social Care Management (CeRGAS), Bocconi University, Via Roentgen 1, Milan, Italy. · Yale Cancer Center, Yale School of Medicine, New Haven, CT, United States. · Translational Breast Cancer Genomics and Therapeutics Lab, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Centre Hospitalier Universitaire du Sart Tilman Liege and Liege University, Liège, Belgium. · U.O. di Patologia Mammaria-Breast Cancer Unit, U.S. Terapia Molecolare e Farmacogenomica, AO-Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Department of Policy Analysis and Public Management, Bocconi University, Via Roentgen 1, Milan, Italy. · Pubmed 26044370
  • : Department of Pathology (DECH, KAS, DLR) and Medical Oncology (LP), Yale University School of Medicine, New Haven, CT; Attikon University Hospital, Athens, Greece (AP); Translational Research Section, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece (KTK); Department of Medical Oncology, "Papageorgiou" Hospital (KTK, GF), Department of Pathology (VK), and Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research (VK, GF), Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece. · : Department of Pathology (DECH, KAS, DLR) and Medical Oncology (LP), Yale University School of Medicine, New Haven, CT; Attikon University Hospital, Athens, Greece (AP); Translational Research Section, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece (KTK); Department of Medical Oncology, "Papageorgiou" Hospital (KTK, GF), Department of Pathology (VK), and Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research (VK, GF), Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece. · Pubmed 25991002
  • Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · Department of Surgery, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · Department of Medicine, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · Pubmed 25902916
  • Department of Surgery, Yale University School of Medicine, and Yale Comprehensive Cancer Center, New Haven, CT 06520. Electronic address: · Department of Epidemiology, Yale University School of Medicine, and Yale Comprehensive Cancer Center, New Haven, CT 06520. · Department of Medicine, Yale University School of Medicine, and Yale Comprehensive Cancer Center, New Haven, CT 06520. · Department of Surgery, Yale University School of Medicine, and Yale Comprehensive Cancer Center, New Haven, CT 06520. · Pubmed 25868410
  • Yale University School of Public Health; and Yale University School of Medicine, New Haven, CT. · Yale University School of Public Health; and Yale University School of Medicine, New Haven, CT · Pubmed 25784577
  • Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · Cell Signaling Technology, Inc., Danvers, Massachusetts. · Department of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut. · Department of Surgery, Yale University School of Medicine, New Haven, Connecticut. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · Pubmed 25527356
  • Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science (Scotland) Ltd., Inverness-shire, Scotland. · Clinical Research, Monogram Biosciences, Inc., South San Francisco, California. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Center, Department of Obstetrics and Gynecology, and CCC LMU, University of Munich, Munich, Germany. · Genetics and Genomics Program, Yale School of Medicine, New Haven, Connecticut. · Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania. · Department of Gynecology and Midwifery, University Hospital Kiel, Kiel, Germany. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25467182
2014
  • Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · New York University Langone Medical Center, New York University, New York, New York. · Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Bristol-Myers Squibb Inc., New York, New York. · Pubmed 25172932
  • Department of Breast Medical Oncology Department of Systems Biology · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology. · Genenetech, San Francisco. · Departments of Biostatistics. · Clinical Cancer Prevention. · Radiology. · Pathology, The University of Texas MD Anderson Cancer Center, Houston. · Division of Hematology-Oncology, Yale University, New Haven. · Department of Systems Biology. · Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 24669015
  • 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [4] Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] INSERM, U848, Villejuif, France. · 1] INSERM, U848, Villejuif, France. [2] Equipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [3] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Regina Elena National Cancer Institute, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Transgene S.A., Illkirch-Graffenstaden, France. · Laboratory for Genomics and Immunoregulation, Life and Medical Sciences (LIMES), University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology, University Hospital Bonn, Bonn, Germany. · Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] SIB-Swiss Institute of Bioinformatics, Lausanne, Switzerland. [2] National Center of Competence in Research (NCCR) Molecular Oncology, Institut Suisse de Recherche Expérimentale sur le Cancer (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. [3] Departement de Formation et Recherche, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Department of Pathology, Centre Claudius Regaud, Toulouse, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. [4] Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Yale School of Medicine, New Haven, Connecticut, USA. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Pathology, Jean Perrin Center, EA 4677 ERTICa, University of Auvergne, Clermont-Ferrand, France. · 1] Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. [2] INSERM, CRI-866 Faculty of Medicine, Dijon, France. [3] University of Burgundy, Dijon, France. · Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · San Raffaele University and Scientific Institute, Milan, Italy. · 1] Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts, USA. [2] Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Transgene S.A., Illkirch-Graffenstaden, France. · CNRS UMR5235, University Montpellier II, Place Eugène Bataillon, Montpellier, France. · Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA. · Queensland Institute of Medical Research, Herston, Queensland, Australia. · 1] Queensland Institute of Medical Research, Herston, Queensland, Australia. [2] School of Medicine, The University of Queensland, Herston, Queensland, Australia. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [4] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. [5] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U848, Villejuif, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. [4] Metabolomics Platform, Gustave Roussy Cancer Campus, Villejuif, France. [5] Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · Pubmed 25344738
  • Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Pubmed 24957076
  • Authors' Affiliations: Departments of Pathology and Medical Oncology, Yale School of Medicine, New Haven, Connecticut; and Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, Ohio · Authors' Affiliations: Departments of Pathology and Medical Oncology, Yale School of Medicine, New Haven, Connecticut; and Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, Ohio. · Pubmed 24647569
  • Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. · Department of Pathology, UT M.D. Anderson Cancer Center, P.O. Box 85, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Department of Bioinformatics and Computational Biology, UT M.D. Anderson Cancer Center, P.O. Box 301402, Houston, TX 77230, USA. · Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. Electronic address: · Pubmed 24602449
  • Research Laboratory of Pediatrics and Nephrology, Hungarian Academy of Sciences, Budapest, Hungary; Oncogenomic Research Group, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato 59100, Italy. · Department of Biochemistry and INSERM U944, University Rene Diderot, Paris 7, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France. · Pathobiochemistry Research Group of Hungarian Academy of Sciences, Semmelweis University, Department of Medicinal Chemistry, 1444, Bp. 8, POB 260, Hungary; Vichem Chemie Research Ltd, 1022, Herman Otto 15, Budapest, Hungary. · Vichem Chemie Research Ltd, 1022, Herman Otto 15, Budapest, Hungary; Department of Pharmaceutical Chemistry, Semmelweis University, Budapest, Hungary. · Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan. · Breast Cancer Translational Laboratory, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium. · Division of Medical Oncology, San Raffaele - Scientific Institute, Milan, Italy. · The Breakthrough Breast Cancer Research Center, Institute of Cancer Research, London, UK. · Department of Medical Oncology, Institut National de la Santé et de la Recherche Médicale Unit U981, Institut Gustave Roussy, Villejuif, France. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medical Oncology Unit Sandro Pitigliani, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Yale Cancer Center, New Haven, CT, USA. · Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato 59100, Italy. Electronic address: · Pubmed 24462521
  • Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, 450 Brookline Ave. Boston, MA 02215. · Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215. · Foundation Medicine, One Kendall Sq. Cambridge, MA 02139. · Departments of Investigational Cancer Therapeutics, Surgical Oncology, The University of MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030. · Departments of Systems Biology, and Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030. · Fundacion de Investigacion INCLIVA - Institute for Health Reseearch, Valencia, Spain. · Departments of Hematology-Oncology, Hospital Clinico Universitario de Valencia, Valencia, Spain. · Jefferson Breast Care Center, Kimmel Cancer Center, Thomas Jefferson University, 925 Chestnut St. Philadelphia, PA 19107. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 2220 Pierce Ave, Nashville, TN 37232. · Teva Pharmaceuticals, 5 Basel St. Petach Tikva, Israel 49131. · Oncology Division, Tel Aviv Sourasky Medical Center , 6 Weizmann St. Tel Aviv 64239, Israel. · Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave. Boston MA 02215. · Breast Medical Oncology Program, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave. Boston MA 02215. · Section of Breast Medical Oncology, Yale School of Medicine, New Haven, South Frontage Rd and Park St. CN, 06510. · Pubmed 24398047
2017
  • W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Xian Yu, Ya Zhang, Maheshwari Ramineni, Kelly Hunt, Thomas A. Buchholz, Vicente Valero, Aman U. Buzdar, Wei Yang, Abenaa M. Brewster, Stacy Moulder, and Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston; Andrew Walls, Uniformed Services University of the Health Sciences, San Antonio, TX; Mei Liu, The General Hospital of People's Liberation Army, Beijing, China; Alex Bousamra, Allegheny General Hospital, Pittsburgh, PA; Bruno Sinn, Charite-Universitatsmedizin, Berlin, Germany; and Lajos Pusztai and Christos Hatzis, Yale University School of Medicine, New Haven, CT. · Pubmed 28135148
  • *Department of Surgery, Yale University †Yale Cancer Center ‡Yale Center for Outcomes Public Policy and Effectiveness Research §Department of Surgery, Thomas Jefferson University ¶Yale-New Haven Hospital ||Yale Center for Analytical Sciences **Department of Pathology, Yale University ††Department of Medicine, Yale University. · Pubmed 27192352
2016
  • Rita Nanda, University of Chicago, Chicago, IL; Laura Q.M. Chow, University of Washington, Seattle, WA; E. Claire Dees, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Raanan Berger, Sheba Medical Center, Tel Hashomer; Ravit Geva, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Lajos Pusztai, Yale University School of Medicine, New Haven, CT; Kumudu Pathiraja, Gursel Aktan, Jonathan D. Cheng, and Vassiliki Karantza, Merck & Co., Kenilworth, NJ; and Laurence Buisseret, Université Libre de Bruxelles, Bruxelles, Belgium. · Rita Nanda, University of Chicago, Chicago, IL; Laura Q.M. Chow, University of Washington, Seattle, WA; E. Claire Dees, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Raanan Berger, Sheba Medical Center, Tel Hashomer; Ravit Geva, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Lajos Pusztai, Yale University School of Medicine, New Haven, CT; Kumudu Pathiraja, Gursel Aktan, Jonathan D. Cheng, and Vassiliki Karantza, Merck & Co., Kenilworth, NJ; and Laurence Buisseret, Université Libre de Bruxelles, Bruxelles, Belgium. · Pubmed 27138582
  • aDepartmentof Medical Oncology, Yale Cancer Center, Yale School of Medicine bDepartment of Social and Behavioral Sciences, Yale School of Public Health, New Haven, Connecticut, USA cDepartment of Medical Oncology, Marmara University Pendik Training and Research Hospital, Marmara University School of Medicine, Ust Kaynarca, Istanbul, Turkey. · Pubmed 25642790
2015
  • From the Departments of Surgery (A.B.C., B.K.K., M.B., K.S., D.R.L., N.R.H.), Pathology (V.B., M.H.), and Medicine (L.P.), Yale Cancer Center (A.B.C., B.K.K., M.B., K.S., F.L., X.Y., D.R.L., L.P., N.R.H.), and Yale Center for Analytical Sciences (F.L., X.Y.), Yale University School of Medicine, New Haven, CT; and the Department of Surgery, Thomas Jefferson University, Philadelphia (T.N.T.). · Pubmed 26028131
  • Yale University School of Medicine, New Haven, CT, USA, · Pubmed 25651779
2014
  • Department of Internal Medicine, Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut, USA. · Pubmed 25294321
  • Yale University School of Medicine, New Haven, Connecticut, USA; Foundation Medicine, Cambridge, Massachusetts, USA; MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 24710307
  • Yale Cancer Center, Yale School of Medicine, Yale University, 333 Cedar St, PO Box 208032, New Haven, CT, 06520, USA. · Pubmed 24619174
  • Authors' Affiliations: Departments of Breast Medical Oncology, Biostatistics, Pathology, Systems Biology, and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Division of Hematology-Oncology, Yale University, New Haven, Connecticut. · Pubmed 24296856
2013
  • Yale University School of Medicine, Yale Cancer Center, Section of Breast Medical Oncology, 333 Cedar St, PO Box 208032, New Haven, CT 06520-8032, USA. Electronic address: · Pubmed 24074799
University of Texas Houston
2016
  • Hannah Dzimitrowicz, Annette Hood, Osama Abdelghany, Christos Hatzis, and Lajos Pusztai, Yale University School of Medicine, New Haven, CT; Michael Berger and Craig Vargo, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH; and Akshara Singareeka Raghavendra, Debu Tripathy, Vicente Valero, and Rashmi Murthy, MD Anderson Cancer Center, Houston, TX. · Pubmed 27298406
2015
  • 1] Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. [2] Graduate School of Biomedical Sciences, The University of Texas at Houston, Houston, TX 77030, USA. · Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · 1] Graduate School of Biomedical Sciences, The University of Texas at Houston, Houston, TX 77030, USA. [2] Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Methodist Hospital Research Institute, Houston, TX 77030, USA. · Department of Endocrinology Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · 1] Department of Endocrinology Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. [2] Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 26179207
2014
  • Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Pubmed 24957076
  • 1] Breast Cancer Translational Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [2] Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [3] Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo, Japan. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo, Japan. · 1] Breast Cancer Translational Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [2] Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Pubmed 23376849
2011
  • Department of Breast Medical Oncology, UT MD Anderson Cancer Center, P.O. Box 301439, Houston, TX 77230-1439, USA. · Pubmed 20464478
2010
  • Department of Breast Medical Oncology, M. D. Anderson Cancer Center, Houston, Tx 77230-1439, USA. · Pubmed 21041379
2009
  • Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA. · Pubmed 20030862
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, PO Box 301439, Houston, TX 77230-1439, USA. · Pubmed 19667268
2017
  • W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Xian Yu, Ya Zhang, Maheshwari Ramineni, Kelly Hunt, Thomas A. Buchholz, Vicente Valero, Aman U. Buzdar, Wei Yang, Abenaa M. Brewster, Stacy Moulder, and Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston; Andrew Walls, Uniformed Services University of the Health Sciences, San Antonio, TX; Mei Liu, The General Hospital of People's Liberation Army, Beijing, China; Alex Bousamra, Allegheny General Hospital, Pittsburgh, PA; Bruno Sinn, Charite-Universitatsmedizin, Berlin, Germany; and Lajos Pusztai and Christos Hatzis, Yale University School of Medicine, New Haven, CT. · Pubmed 28135148
2016
  • From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California; University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago; University of Pennsylvania, Philadelphia (A.D.); Gemini Group, Ann Arbor, MI (J.P.); University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas; University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota; Swedish Medical Center, Seattle (H.G.K.); Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.); University of Kansas, Lawrence (Q.J.K.); University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona; Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.); University of Denver, Denver (A.D.E.); Inova Fairfax Hospital, Falls Church, VA (K.K.E.); and Emory University, Atlanta (W.C.W.). · Pubmed 27406347
  • From University of California, San Francisco (J.W.P., C.Y., L.J.V., N.M.H., M.B.B., A.J.C., M.M., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California, San Diego, San Diego (A.M.W., R.S., T.H.), and University of Southern California, Los Angeles (D.T.) - all in California; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.); University of Minnesota, Minneapolis (D.Y., T.C.H.), and Mayo Clinic, Rochester (J.C.B.) - both in Minnesota; M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), University of Texas Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas; Gemini Group, Ann Arbor, MI (J.P.); University of Pennsylvania, Philadelphia (A.D.); Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.); Swedish Medical Center, Seattle (H.G.K.); University of Chicago (R.N.) and Loyola University (K.S.A.) - both in Chicago; Inova Fairfax Hospital, Falls Church, VA (K.K.E.); University of Denver, Denver (A.D.E.); Mayo Clinic, Scottsdale (D.W.N.), and University of Arizona, Tucson (J.E.L., R.K.V.) - both in Arizona; University of Kansas, Lawrence (Q.J.K.); and Emory University, Atlanta (W.C.W.). · Pubmed 27406346
2014
  • Yale University School of Medicine, New Haven, Connecticut, USA; Foundation Medicine, Cambridge, Massachusetts, USA; MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 24710307
  • Authors' Affiliations: Departments of Breast Medical Oncology, Biostatistics, Pathology, Systems Biology, and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Division of Hematology-Oncology, Yale University, New Haven, Connecticut. · Pubmed 24296856
2013
  • Authors' Affiliations: Department of Breast Medical Oncology, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Departments of Molecular and Cellular Oncology, Pathology, Radiation Oncology, and Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Tolero Pharmaceuticals, Inc., Salt Lake City, Utah; and Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan. · Pubmed 24014597
  • Departmentsof Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23337751
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 23299541
  • Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 23242617
  • Department of Surgical Oncology, Unit 1484, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77030, USA. · Pubmed 23208590
2012
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, PO Box 301439, Houston, TX 77230-1439, USA. · Pubmed 22890751
  • Department of Radiation Oncology, 1515 Holcombe Blvd,, University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA. · Pubmed 22559056
  • Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22370716
  • Department of Systems Biology - Unit 950, The University of Texas MD Anderson Cancer Center, 7435 Fannin Street, Houston, TX 77054, USA. · Pubmed 22343619
  • The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA. · Pubmed 22291085
  • Departments of Breast Medical Oncology, Systems Biology, Biostatistics, Surgical Oncology, and Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22235097
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21823108
2011
  • Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 22132775
  • Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77230-1439, USA. · Pubmed 22043042
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, TX 77030-4009, USA. · Pubmed 21900106
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77230-1439, USA. · Pubmed 21833625
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., 77030, Houston, TX, USA. · Pubmed 21710134
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1439, USA. · Pubmed 21248301
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77230-1439, USA. · Pubmed 21191116
  • Breast Cancer Translational Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21153052
  • Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 21061075
  • Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 20939012
2010
  • Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, United States. · Pubmed 20739212
  • Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA. · Pubmed 21172090
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77230-1439, USA. · Pubmed 20829329
  • Department of Breast Medical Oncology, Unit 1354, The University of Texas M. D. Anderson Cancer Center, PO Box 301439, Houston,TX 77230-1439, USA. · Pubmed 20805453
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 20697068
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 20665886
  • Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20665494
  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20423993
  • Department of Breast Medical Oncology, The University of Texas,M.D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 20421265
  • FACP, Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Unit 1354, Houston, TX 77030, USA. · Pubmed 20308667
  • Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 20231683
  • Department of Breast Medical Oncology, Unit 1354, The University of Texas M. D. Anderson Cancer Center, P.O. Box 301439, Houston, TX 77230-1439, USA. · Pubmed 20024612
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, BO Box 301439, Houston, TX 77030-1439, USA. · Pubmed 19603265
2009
  • Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA. · Pubmed 19887608
  • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77039, USA. · Pubmed 19596702
Ohio State University
2016
  • Hannah Dzimitrowicz, Annette Hood, Osama Abdelghany, Christos Hatzis, and Lajos Pusztai, Yale University School of Medicine, New Haven, CT; Michael Berger and Craig Vargo, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH; and Akshara Singareeka Raghavendra, Debu Tripathy, Vicente Valero, and Rashmi Murthy, MD Anderson Cancer Center, Houston, TX. · Pubmed 27298406
Attikon General Hospital
2015
  • : Department of Pathology (DECH, KAS, DLR) and Medical Oncology (LP), Yale University School of Medicine, New Haven, CT; Attikon University Hospital, Athens, Greece (AP); Translational Research Section, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece (KTK); Department of Medical Oncology, "Papageorgiou" Hospital (KTK, GF), Department of Pathology (VK), and Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research (VK, GF), Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece. · : Department of Pathology (DECH, KAS, DLR) and Medical Oncology (LP), Yale University School of Medicine, New Haven, CT; Attikon University Hospital, Athens, Greece (AP); Translational Research Section, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece (KTK); Department of Medical Oncology, "Papageorgiou" Hospital (KTK, GF), Department of Pathology (VK), and Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research (VK, GF), Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece. · Pubmed 25991002
Aristotle University of Thessaloniki
2015
  • : Department of Pathology (DECH, KAS, DLR) and Medical Oncology (LP), Yale University School of Medicine, New Haven, CT; Attikon University Hospital, Athens, Greece (AP); Translational Research Section, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece (KTK); Department of Medical Oncology, "Papageorgiou" Hospital (KTK, GF), Department of Pathology (VK), and Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research (VK, GF), Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece. · : Department of Pathology (DECH, KAS, DLR) and Medical Oncology (LP), Yale University School of Medicine, New Haven, CT; Attikon University Hospital, Athens, Greece (AP); Translational Research Section, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece (KTK); Department of Medical Oncology, "Papageorgiou" Hospital (KTK, GF), Department of Pathology (VK), and Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research (VK, GF), Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece. · Pubmed 25991002
Cleveland Clinic
2014
  • Authors' Affiliations: Departments of Pathology and Medical Oncology, Yale School of Medicine, New Haven, Connecticut; and Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, Ohio · Authors' Affiliations: Departments of Pathology and Medical Oncology, Yale School of Medicine, New Haven, Connecticut; and Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, Ohio. · Pubmed 24647569
Texas A and M University
2014
  • Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Affiliations of authors: University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX (GV-T, LPh, FZ, P-CC, J-HS, HHC, CG, CC, FJE, M-HL, S-CJY); Cancer Biology Graduate Program (GV-T, P-CC, J-HS, HHC, CC, M-HL), Genes and Development Graduate Program (CG, M-HL); Department of Molecular and Cellular Oncology (EF-M, GV-T, LPh, FZ, P-CC, J-HS, HHC, RZ, JC, CG, CC, FJE, M-HL), Department of Breast Medical Oncology (FJE, GNH, LPu); Department of Biostatistics (JE), Department of Bioinformatics and Computational Biology (YQ); Department of Pathology (YZ, YW, WFS); Department of Emergency Medicine (J-SC, S-CJY), and Department of Endocrine Neoplasia and Hormonal Disorders (S-CJY), The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Cancer & Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX (YL, WLM); Present address: Breast Cancer Program, Yale Cancer Center, New Haven, CT (LPu). · Pubmed 24957076
73 Other Locations Show
Yearly article counts 1161523161718252260
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.